cose-lowering and insulin-sensitizingactions of exendin-4: studies in obesediabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys(Macaca mulatta). Diabetes 48:1026– 1034, 1999 28. Parkes DG, Pittner R, Jodka C, Smith P, Young A: Insulinotropic actions of ex-endin-4 and glucagon-like peptide-1 invivo and in vitro. Metabolism 50:583–589, 2001 29. Edwards CM, Stanley SA, Davis R, Brynes AE, Frost GS, Seal LJ, Ghatei MA, BloomSR: Exendin-4 reduces fasting and post-prandial glucose and decreases energy in-take in healthy volunteers. Am J Physiol Endocrinol Metab 281:E155–E161, 2001 30. Egan JM, Clocquet AR, Elahi D: The insu- linotropic effect of acute exendin-4 ad-ministered to humans: comparison ofnondiabetic state to type 2 diabetes. J Clin Endocrinol Metab 87:1282–1290, 2002 31. Go ¨ke R, Fehmann HC, Linn T, Schmidt